Objective: During bubble nasal continuous positive airway pressure (B-NCPAP), gas flows through the expiratory limb of CPAP tubing submerged underwater to a depth in centimeters considered equal to the desired end expiratory pressure. Ventilator-derived NCPAP (V-NCPAP) controls the delivered pressure at the expiratory orifice. Limited data exist comparing the two forms of NCPAP on work of breathing (WOB) and other short-term respiratory outcomes. We compared WOB and gas exchange between B-NCPAP and V-NCPAP at equivalent delivered nasal prong pressures among a cohort of preterm infants on NCPAP.
Introduction
Nasal continuous positive airway pressure (NCPAP) is a noninvasive mode of respiratory support that maintains lung volume and may reduce the need for intubation, thereby potentially reducing morbidities associated with mechanical ventilation. 1, 2 The two types of NCPAP commonly used in the neonatal intensive care unit are ventilator-derived NCPAP (V-NCPAP) and bubble NCPAP (B-NCPAP). During V-NCPAP, flow is constant and the CPAP level is maintained at the distal expiratory-limb orifice, which adjusts to keep the delivered CPAP at the desired level. During B-NCPAP, the expiratory limb of the CPAP tubing is immersed in an underwater chamber to a depth in centimeters equal to the 'desired' cm H 2 O CPAP level. The flow of gas through the system creates bubbling in the chamber. B-NCPAP is popular as it is favored by an institution reporting a low incidence of chronic lung disease. 3 Benefits to gas exchange and lung recruitment during B-NCPAP, due to the high-frequency oscillatory content of the bubbling, have been hypothesized. [4] [5] [6] [7] It is still a widely held belief that the delivered mean intraprong pressure during B-NCPAP may be estimated by the submersion depth of the expiratory tubing and is independent of the flow rate. 8 However, the bubbling in a B-NCPAP system causes variability in the delivered mean B-NCPAP pressure, and has been shown to be dependent on the bias flow rate. 6 We have previously shown in both a lung model and in premature infants that pressure delivered to the nasal prongs in a B-NCPAP system is greater than the immersion depth of the expiratory tubing, even at the lowest flow that causes gentle continuous bubbling. 9, 10 We also showed that this pressure overshoot was systematically greater as the flow magnitude increased. By comparison, V-NCPAP-delivered pressures were equal to the set (desired) pressures and exhibited little flow dependence. In addition, as with any CPAP modality, the effective intrapulmonary NCPAP delivery was substantially influenced by air leaks. 9, 10 Few studies exist comparing B-NCPAP to V-NCPAP and it is unknown whether some of these studies ensured equivalent delivered pressures rather than just equivalent set pressures. Lee et al. 4 compared two devices in 10 endotracheally intubated infants and found decreased minute volume and respiratory rate (RR) with B-NCPAP, but no differences in transcutaneous (Tc) O 2 or TcCO 2 . Most recently, Pillow et al. 7 found that intubated preterm lambs on B-CPAP had improved short-term respiratory outcomes compared to those on V-CPAP. Whether the results found in these studies apply to CPAP applied to premature infants through the nasal route rather than through an endotracheal tube is unknown. One previous study has shown that infant flow NCPAP (IF-NCPAP) improves work of breathing (WOB) and respiratory asynchrony in premature infants compared to both B-NCPAP and V-NCPAP, 11 whereas another recent study found lower extubation failure rates and shorter duration of CPAP support with B-NCPAP compared to infant flow NCPAP in low-birth-weight infants ventilated for less than 14 days. 12 There are no published studies comparing respiratory parameters between B-NCPAP and V-NCPAP in infants while ensuring equal pressure delivery at the nasal prongs.
The objectives of this study were to compare WOB and other short-term respiratory outcomes between B-NCPAP and V-NCPAP at equivalent delivered nasal prong pressures among a cohort of preterm infants on NCPAP.
Methods

Patient recruitment
Using inspiratory work of breathing (WOB insp ) as the primary outcome variable, sample size calculations indicated that 18 subjects would be needed to show a 50% or greater difference between devices at a ¼ 0.05 and b ¼ 0.20. Eighteen preterm infants <1500 g birth weight requiring NCPAP for mild respiratory distress (FiO 2 p0.40, to assure tolerance of study procedures) were recruited. Infants with airway anomalies, other major congenital anomalies or >28 days of life were excluded. The protocol was approved by the North Shore Long Island Jewish Health System IRB, and written consent was obtained from both parents before study. Infants were studied on both devices; order of device was randomized. Data on effects of flow amplitudes on delivered bubble and ventilator NCPAP were previously reported 10 from a subset of the infants in the current analysis.
Instrumentation. A calibrated pressure transducer (Validyne DP45-28; Northridge, CA, USA) was used to measure intraprong pressure. Data were collected using a computerized data acquisition system (Biopac Systems, Goleta, CA, USA) at a sampling rate of 200 Hz s À1 per channel. V-NCPAP was given using a calibrated VIP Bird infant ventilator (VIASYS HealthCare, Yorba Linda, CA, USA) with V-NCPAP provided using the positive end expiratory pressure control. The exhalation valve on this ventilator is under microcomputer control and works in conjunction with the exhalation valve pressure transducer to control CPAP.
For B-NCPAP, we devised a system that allowed easy conversion from V-NCPAP to B-NCPAP and was similar to commonly used B-NCPAP systems. We submerged the expiratory limb of the ventilator tubing (length 185 cm, internal diameter 1 cm, noncorrugated tubing) in a chamber of water made specifically for delivery of B-NCPAP (Airways Development LLC, Kenilworth, NJ, USA; diameter 7.5 cm) to the level of NCPAP desired (cm H 2 O). We have previously shown that this tubing length minimally affects the pressure at the prongs. 9 Hudson prongs (Hudson Respiratory Care, Temecula, CA, USA) were used in all infants on both devices. The largest prongs that fit comfortably in the infant's nares without blanching the surrounding tissue were used. Intraprong pressure monitoring was accomplished through the Hudson prongs pressure monitoring port and attached to the expiratory tubing as previously described. 10 Minimal to no-leak conditions were also assured during data collection by gently holding the infant's mouth closed, if necessary.
Measurements. Data acquisition and analysis methods are described elsewhere in detail. 13 Briefly, abdominal and chest wall movements were recorded using calibrated respiratory inductance plethysmography (RIP) (Respiband Plus and Respitrace; SensorMedics, Yorba Linda, CA, USA). A face mask with attached pneumotachometer (8411 series, unheated, 0-10LPM; Hans Rudolph, Kansas City, MO, USA) was used to calibrate RIP by direct comparison to leak-free flow and volume data over a series of breaths. Pleural pressures were estimated using an esophageal balloon catheter (Ackrad Laboratories, Cranford, NJ, USA). Proper placement of the esophageal catheter was confirmed using the occlusion technique.
14 Infants were studied supine, without sedation and after feeding. After instrumentation and calibration of RIP, we first placed each infant on B-NCPAP to determine the lowest constant flow that provided continuous gentle bubbling at the highest NCPAP setting used in the study (7 cm H 2 O). Therefore, flow varied among infants but was constant when comparing V-NCPAP to B-NCPAP for each infant. Each infant was then studied at varying pressures of 3, 5, 7, 4 and 2 cm H 2 O in that order, to simulate lung recruitment and derecruitment, while on each device. Order of device was randomized. After 5 min of stabilization at each setting, we collected data continuously and analyzed breaths obtained during the last 20 to 30 s of quiet breathing.
Mean nasal prong pressures were analyzed to ensure equivalency of delivered pressure. Calibrated RIP tracings and transpulmonary pressure changes (DP tp ) obtained from the esophageal pressure tracings were used to obtain tidal volume (V T ), respiratory rate (RR), minute ventilation (V E ), and lung compliance (C L ). Also, phase angle (y, in degrees, time lag between chest and abdominal movement) was calculated from RIP tracings. In addition, TcO 2 , TcCO 2 (Radiometer, Westlake, OH, USA), heart rate and oxygen saturation (Masimo, Irvine, CA, USA) were continuously monitored and recorded through the data acquisition system. Finally, V T and P tp were used to calculate inspiratory, expiratory and resistive work of breathing (WOB insp , WOB elast and RWOB) as previously described. 15 Results were analyzed using two-way analysis of variance (ANOVA) for repeated measures controlling for NCPAP device and NCPAP level.
Results
Demographic and baseline respiratory support data for the 18 infants enrolled in the study are shown in Table 1 . Mean birth weight was 1101 ± 254 g, gestational age 28 ± 2 weeks and age at study 13 ± 8 days (mean ± s.d.). Thirteen infants were on NCPAP of 5 cm H 2 O and 5 were on 6 cm H 2 O before the study. Mean FiO 2 before study initiation for each patient was 0.24 (range 0.21 to 0.4). The mean flow (lowest flow required to generate gentle continuous bubbling on B-NCPAP for each infant) used during the study was 6.7±1.1 (range 5 to 9) l min À1 . Figure 1 shows nearly identical nasal prong pressures while on each device (r 2 ¼ 0.98). We were therefore able to successfully provide equivalent delivered pressures to make comparisons between the two devices meaningful. Figure 2 shows that for work of breathing (WOB insp , WOB elast and RWOB), there were no statistically significant differences between the two devices. Tidal volume, respiratory rate and phase angle were likewise not different between devices (Figure 3) . Minute ventilation and lung compliance (C L ) were also not different (results not shown). Heart rate, SaO 2 and TcCO 2 were not different between devices at all settings, whereas TcO 2 was found to be higher during B-NCPAP, P ¼ 0.01 ( Figure 4 ).
Discussion
Noninvasive forms of respiratory support such as NCPAP have been shown to be effective for certain premature infants in the management of respiratory distress syndrome, and to decrease the rates of extubation failure. 16, 17 However, the response of infants to NCPAP is highly variable, and is a complex interaction between the infant, the method of NCPAP delivery and how the clinician chooses to deliver NCPAP.
We have previously shown in both a lung model and in premature infants on NCPAP that although delivered V-NCPAP is Abbreviations: BW, birth weight; GA, gestational age. largely flow independent, B-NCPAP is highly flow dependent. 9, 10 We have also shown that delivered mean pressure is higher than set B-NCPAP, and therefore, when comparing B-NCPAP to V-NCPAP in infants, it is important to ensure equivalent delivered pressures. 10 This study is the first to compare B-NCPAP and V-NCPAP in premature infants on NCPAP while ensuring equivalent delivered pressures. Lee et al. 4 concluded that the chest vibrations produced by B-CPAP may have contributed to gas exchange. We have previously shown in a lung model that the pressure oscillations on B-NCPAP that are so prominent at the nasal prong level are markedly diminished at the alveolar level, especially once leak is introduced into the system, a feature that is unavoidable in non-intubated subjects. 9 In a study of intubated preterm lambs randomized to B-CPAP or V-CPAP by Pillow et al., 7 B-CPAP was associated with a higher pH, PaO 2 , oxygen uptake and area under the flow-volume curve, and decreased alveolar protein, respiratory quotient, PaCO 2 and ventilation inhomogeneity compared with V-CPAP. Once again, this was a study of intubated preterm lambs that may not be applicable to infants on nasal CPAP. They also found, however, that increasing the intensity of the flow rate on B-CPAP did not have additional benefits over lower flow rates. This is in keeping with a study by Morley et al. 6 that found an increased CPAP prong pressure but no difference in TcPCO 2 , TcPO 2 , SaO 2 and RR between a low flow-rate and higher flow-rate group of premature infants on B-NCPAP. We found little difference in most short-term respiratory outcomes tested between B-NCPAP and V-NCPAP; however, TcO 2 was higher in our study during B-NCPAP.
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Even though the TcO 2 was statistically higher during B-NCPAP, whether this is of clinical significance is open to question. None of these infants had indwelling arterial lines and thus actual PO 2 values could not be obtained. The greatest difference was obtained at an NCPAP of 3 cm H 2 O, a level seldom if ever used clinically. At an NCPAP of 5 cm H 2 O, more often clinically used, the difference was quite small. TcO 2 monitoring is very useful for trends but may not accurately reflect the actual PO 2 values, whereas TcCO 2 may more closely reflect PCO 2. In addition, the SaO 2 values were not different, and saturations were predominantly in the lower 90s; thus more accurately reflecting PO 2 values than if saturations had been higher, given the oxygen-hemoglobin dissociation curve. Thus, these results must be interpreted with caution.
Whether the oscillations of bubbling during B-NCPAP applied with nasal prongs can contribute in any way to gas exchange is unknown. Though specific characteristics of the bubbling may affect the oscillatory waveform and thus perhaps the efficiency of enhanced CO 2 diffusion, oxygenation and WOB, this must be validated in studies assuring that delivered pressures are equal between compared devices. Though the greater high-frequency content of bubbling can be clearly seen at the level of the prongs (Figure 5 ), neither the RIP bands nor the esophageal balloon catheter were sensitive enough to accurately reflect oscillations at the chest and abdomen or intrapleurally ( Figure 5 ). The RIP bands act as a low-pass filter, as did the esophageal balloon thus removing high frequency information. Use of an accelerometer in future studies might better show the oscillations present distal to the nasal prongs.
There are several limitations to this study. We studied a cohort of relatively well, moderately preterm infants who were on NCPAP with relatively low FiO 2 before study initiation. Whether the same outcomes would be supported in sicker or severely preterm infants is unknown. Because of the study design, this type of study Figure 4 Transcutaneous oxygen (TcO 2 ), transcutaneous carbon dioxide (TcCO 2 ), heart rate and oxygen saturations (SaO 2 ) measurements between devices. TcCO 2 , heart rate and SaO 2 differences are not significant. TcO 2 is higher during bubble NCPAP (B-NCPAP) than during ventilator-derived NCPAP (V-NCPAP), P ¼ 0.01. Settings are in cm H 2 O (two-way ANOVA for repeated measures; means ± s.e.).
is not possible in sicker infants, as they have to tolerate periods of minimal to no respiratory support, and even brief occlusions of airway flow. In addition, as these studies are time consuming and difficult, recruitment of large numbers of infants is not feasible. Our study was thus not powered to detect smaller, yet potentially clinically important differences. Though some heterogeneity among infants was present as noted in Table 1 , all infants were only mildly ill.
We also studied outcomes after only 5 min at each setting on each device. Pillow et al. 7 showed that for some outcomes significant differences only appeared after 2 h on each device. Though a longer period may have affected the results, these infants were only mildly diseased and thus this concern is mitigated to some extent, as the majority of lung volume change will occur well within this time period in the normal lung. 18 We were consistent in our protocol with both NCPAP systems and order of application was randomized. The aim of this study was to assess WOB and other short-term respiratory outcomes and so we cannot draw conclusions about long-term clinical importance from a short-term physiological study.
In summary, WOB, breathing asynchrony and most other shortterm respiratory outcomes were similar between B-NCPAP and V-NCPAP when compared at the same delivered NCPAP levels. Improved TcO 2 during B-NCPAP levels raises the question of whether the oscillations of B-NCPAP may contribute to improved oxygenation when compared to V-NCPAP. Future studies should attempt to measure the high-frequency content of oscillations distal to the nasal prongs during B-NCPAP. 
